New Key Statistics Module, Z-Score and F-Score
NAS:LGND Key Ratios
Market Cap $ M | 1,545.95 |
Enterprise Value $ M | 1,241.55 |
P/E(ttm) | 16.18 |
PE Ratio without NRI | 21.83 |
Forward PE Ratio | 25.25 |
Price/Book | 1.91 |
Price/Sales | 12.89 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | 15.97 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 118.00 |
EPS (TTM) $ | 5.32 |
Beneish M-Score | -2.38 |
10-y EBITDA Growth Rate % | 25.40 |
5-y EBITDA Growth Rate % | -21.10 |
y-y EBITDA Growth Rate % | 1.70 |
EV-to-EBIT | 10.17 |
EV-to-EBITDA | 7.91 |
PEG | -- |
Shares Outstanding M | 17.96 |
Net Margin (%) | 81.43 |
Operating Margin % | -1.18 |
Pre-tax Margin (%) | 102.75 |
Quick Ratio | 19.51 |
Current Ratio | 20.70 |
ROA % (ttm) | 11.93 |
ROE % (ttm) | 13.82 |
ROIC % (ttm) | -0.19 |
Dividend Yield % | -- |
Altman Z-Score | 10.57 |
LGND Number of Guru Trades
LGND Volume of Guru Trades
Gurus Latest Trades with NAS:LGND
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:LGND is held by these investors
Total 1
Ligand Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:LGND
Total 0- 1